Study and Treatment of Post Lyme Disease (STOP-LD)

NCT00000937 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

55

Enrollment

NIH

Sponsor class

Conditions

Lyme Disease

Interventions

DRUG: Antibiotics

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)